[go: up one dir, main page]

BRPI0818618A2 - Compostos antimaláricos com cadeias laterais flexíveis e métodos de tratamento da malária. - Google Patents

Compostos antimaláricos com cadeias laterais flexíveis e métodos de tratamento da malária.

Info

Publication number
BRPI0818618A2
BRPI0818618A2 BRPI0818618-9A BRPI0818618A BRPI0818618A2 BR PI0818618 A2 BRPI0818618 A2 BR PI0818618A2 BR PI0818618 A BRPI0818618 A BR PI0818618A BR PI0818618 A2 BRPI0818618 A2 BR PI0818618A2
Authority
BR
Brazil
Prior art keywords
side chain
treatment methods
flexible side
malaria treatment
antimalarial compounds
Prior art date
Application number
BRPI0818618-9A
Other languages
English (en)
Inventor
Bongkoch Tarnchompoo
Yuthavong Yongyuth
Tirayut Vilaivan
Penchit Chitnumsub
Chawanee Thongpanchang
Sumalee Kamchonwongpaisan
David Matthews
Livia Vivas
Jirundon Yuvaniyama
Susan Charman
William Charman
Sanjay Babu Katiyar
Original Assignee
Medicines Malaria Venture Mmv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medicines Malaria Venture Mmv filed Critical Medicines Malaria Venture Mmv
Publication of BRPI0818618A2 publication Critical patent/BRPI0818618A2/pt
Publication of BRPI0818618B1 publication Critical patent/BRPI0818618B1/pt
Publication of BRPI0818618B8 publication Critical patent/BRPI0818618B8/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI0818618A 2007-10-08 2008-10-08 composto antimalárico, e, composição farmacêutica BRPI0818618B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97837507P 2007-10-08 2007-10-08
US60/978,375 2007-10-08
PCT/US2008/079210 WO2009048957A1 (en) 2007-10-08 2008-10-08 Antimalarial compounds with flexible side-chains

Publications (3)

Publication Number Publication Date
BRPI0818618A2 true BRPI0818618A2 (pt) 2015-08-04
BRPI0818618B1 BRPI0818618B1 (pt) 2020-03-03
BRPI0818618B8 BRPI0818618B8 (pt) 2023-04-25

Family

ID=40534843

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0818618A BRPI0818618B8 (pt) 2007-10-08 2008-10-08 composto antimalárico, e, composição farmacêutica

Country Status (22)

Country Link
US (1) US8530491B2 (pt)
EP (2) EP2194985B1 (pt)
JP (1) JP5603775B2 (pt)
KR (1) KR101578949B1 (pt)
CN (1) CN101820879B (pt)
AU (1) AU2008310898B2 (pt)
BR (1) BRPI0818618B8 (pt)
CA (1) CA2700880C (pt)
CY (1) CY1121598T1 (pt)
DK (1) DK2194985T3 (pt)
ES (1) ES2727015T3 (pt)
HR (1) HRP20190589T1 (pt)
HU (1) HUE044398T2 (pt)
LT (1) LT2194985T (pt)
MX (1) MX2010003739A (pt)
PL (1) PL2194985T3 (pt)
PT (1) PT2194985T (pt)
RU (1) RU2485107C2 (pt)
SI (1) SI2194985T1 (pt)
TR (1) TR201904913T4 (pt)
UA (1) UA105759C2 (pt)
WO (1) WO2009048957A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9611503B2 (en) 2011-02-09 2017-04-04 National Science And Technology Development Agency Escherichia coli cell line with thyA knockout and folA knockout
WO2012121682A2 (en) * 2011-03-10 2012-09-13 National Science And Technology Development Agency Anti-folate antimalarials with dual-binding modes and their preparation
US10011842B2 (en) 2013-09-30 2018-07-03 National Science And Technology Development Agency Escherichia coli cell line with thyA knockout, folA knockout, and one or both of folP knockout, and folK knockout
CN104593406A (zh) * 2015-01-08 2015-05-06 山西医科大学 pIRES/TgDHFR-TS真核表达重组质粒及其构建和应用
WO2017052479A1 (en) * 2015-09-23 2017-03-30 National Science And Technology Development Agency 2,4-diamino-6-ethylpyrimidine derivatives with antimalarial activities against plasmodium falciparum
CN106083742A (zh) * 2016-05-31 2016-11-09 广东工业大学 一种2,4‑二胺基喹唑啉衍生物及其制备方法和应用
AU2021215743B2 (en) * 2020-02-04 2024-06-13 Tsinghua University Inhibitors of malarial and Plasmodium falciparum hexose transporter and uses thereof
CN112961106A (zh) * 2021-03-13 2021-06-15 德州学院 一种4-羟基-6氯喹啉合成新工艺
EP4438596A1 (en) * 2023-03-28 2024-10-02 Université de Lille Diaminopyrimidine derivatives as hdac and dhfr dual-targeting inhibitors and use thereof in preventing and treating malaria
WO2025053796A1 (en) * 2023-09-04 2025-03-13 National Science And Technology Development Agency Hybrid molecules between pyrimidine derivatives and idasanutlin

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4033962A (en) 1975-06-26 1977-07-05 Hoffman-La Roche Inc. 2,4-Diamino-pyrimidine derivatives and processes
GB1546937A (en) * 1976-07-29 1979-05-31 Beecham Group Ltd 2,4-diaminopyrimidine derivatives
FR2397407A2 (fr) * 1977-07-11 1979-02-09 Dick Pierre Derives de 2,4-diamino pyrimidines et leur mise en solution en association avec des sulfamides
OA07362A (fr) * 1980-10-27 1984-06-30 May & Baker Ltd Dérivés de la pyrimidine, leur procédé de préparation et les compositions les contenant.
GB2086386B (en) * 1980-10-27 1984-01-18 May & Baker Ltd Pyrimidine derivatives
US5322858A (en) 1992-02-14 1994-06-21 Jacobus Pharmaceutical Co. Inc. N,N'-substituted imidodicarbonimidic diamides derived from hydroxylamines
RU95113597A (ru) * 1992-12-02 1997-06-10 ФМК Корпорейшн (US) Инсектицидная композиция, способы борьбы с насекомыми
CN1191861C (zh) 1999-05-24 2005-03-09 三共株式会社 含有抗Fas抗体的药物组合物
IT1317826B1 (it) * 2000-02-11 2003-07-15 Dompe Spa Ammidi, utili nell'inibizione della chemiotassi dei neutrofiliindotta da il-8.
US7371758B2 (en) * 2003-03-13 2008-05-13 National Science & Technology Development Agency Antimalarial pyrimidine derivatives and methods of making and using them

Also Published As

Publication number Publication date
RU2010117193A (ru) 2011-11-20
JP5603775B2 (ja) 2014-10-08
UA105759C2 (uk) 2014-06-25
EP2194985A1 (en) 2010-06-16
PT2194985T (pt) 2019-05-30
US8530491B2 (en) 2013-09-10
CA2700880C (en) 2016-03-08
EP2194985B1 (en) 2019-02-20
CY1121598T1 (el) 2020-07-31
CN101820879B (zh) 2013-01-02
EP3546452A1 (en) 2019-10-02
DK2194985T3 (da) 2019-05-20
CA2700880A1 (en) 2009-04-16
WO2009048957A1 (en) 2009-04-16
BRPI0818618B8 (pt) 2023-04-25
RU2485107C2 (ru) 2013-06-20
LT2194985T (lt) 2019-04-10
KR20100094459A (ko) 2010-08-26
HUE044398T2 (hu) 2019-10-28
JP2010540666A (ja) 2010-12-24
AU2008310898A1 (en) 2009-04-16
MX2010003739A (es) 2010-04-21
BRPI0818618B1 (pt) 2020-03-03
KR101578949B1 (ko) 2015-12-18
HRP20190589T1 (hr) 2019-05-31
EP2194985A4 (en) 2012-01-25
ES2727015T3 (es) 2019-10-11
SI2194985T1 (sl) 2019-04-30
WO2009048957A8 (en) 2010-04-22
AU2008310898B2 (en) 2014-05-08
CN101820879A (zh) 2010-09-01
TR201904913T4 (tr) 2019-05-21
US20090099220A1 (en) 2009-04-16
PL2194985T3 (pl) 2019-12-31

Similar Documents

Publication Publication Date Title
BRPI0818618A2 (pt) Compostos antimaláricos com cadeias laterais flexíveis e métodos de tratamento da malária.
BRPI0814889A2 (pt) tratamento com ligantes alfa7-seletivos.
BRPI0906611A2 (pt) Produtos implantáveis compreendendo nanopartículas.
DE602006004866D1 (de) Katheter
DE602007004088D1 (de) Kettenförderer
BRPI0815773A2 (pt) composto, e, medicamento.
BRPI0717339A2 (pt) Reversor de empuxo e nacela de turboélice
EP1855738A4 (en) CATHETER CONNECTOR
DE112007003143A5 (de) Kettenverbindungsglied
DK2173831T3 (da) Brøndbehandling
BRPI0811870A2 (pt) Tratamento e prevenção de influenza
NL2002458A1 (nl) Transportband.
DE602006000045D1 (de) Förderkette
DE602006017356D1 (de) Kernlose gleiskette
BRPI0923796A2 (pt) compostos antivirais, tratamento e ensaio
EP2181946A4 (en) FÖRDERBAND
DE112007002789A5 (de) Laschenkette
BRPI0814935A2 (pt) Tratamento ou prevenção deinfecção por rotavírus
DK1981360T3 (da) Sensorisk prægning
BRPI0922477A2 (pt) transportador.
DE112008000219A5 (de) Laschenkette
NL2001852A1 (nl) Conveyor belt.
FR2915500B1 (fr) Garde-corps.
DE112008001185A5 (de) Laschenkette
EP1899623A4 (en) STAINABLE CHAIN

Legal Events

Date Code Title Description
B15I Others concerning applications: loss of priority
B12F Other appeals [chapter 12.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 03/03/2020, OBSERVADAS AS CONDICOES LEGAIS.

B25D Requested change of name of applicant approved

Owner name: MMV MEDICINES FOR MALARIA VENTURE (CH)

B25G Requested change of headquarter approved

Owner name: MMV MEDICINES FOR MALARIA VENTURE (CH)

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 08/10/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B25A Requested transfer of rights approved

Owner name: NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY (TH)